tiprankstipranks
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market
BIXT
Bioxytran
RESEARCH TOOLSreports

Bioxytran (BIXT) Income Statement

20 Followers

Bioxytran Income Statement

Last quarter (Q2 2026), Bioxytran's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Bioxytran's net income was $-619.93K. See Bioxytran’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -11.54K$ -7.95K$ -8.29K$ -3.64K$ 0.00
Operating Expenses
$ 1.84M$ 2.22M$ 3.82M$ 2.14M$ 4.21M
Depreciation and Amortization
$ 11.54K$ 7.95K$ 8.29K$ 3.64K$ 4.21M
EBITDA
$ -1.84M$ -2.22M$ -3.82M$ -2.13M$ -4.21M
Operating Income
$ -1.85M$ -2.22M$ -3.82M$ -2.13M$ -4.21M
Other Income/Expenses
$ -269.02K$ -156.94K$ -550.11K$ -523.19K$ -313.61K
Pretax Income
$ -2.12M$ -2.38M$ -4.37M$ -2.66M$ -4.53M
Net Income
$ -2.12M$ -2.37M$ -4.28M$ -2.46M$ -4.35M
Per Share Metrics
Basic EPS
$ -0.02$ -0.02$ -0.03$ -0.02$ -0.04
Diluted EPS
$ -0.02$ -0.02$ -0.03$ -0.02$ -0.04
Weighted Average Shares Outstanding
 91.84M 138.60M 134.22M 115.14M 106.25M
Weighted Average Shares Outstanding (Diluted)
 91.84M 138.60M 134.22M 115.14M 106.25M
Currency in USD

Bioxytran Earnings and Revenue History